NYSE: ABBV · Drug Manufacturers - General
Over the past week, Abbvie (ABBV) pulled in about 75 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 29% bullish but is at odds: X runs 56% bullish while Polymarket sits at just 0%. Wall Street is more constructive, with 24 of 31 analysts rating ABBV a buy.
There is little buzz around ABBV this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 77% buy share sits next to a crowd that ranges from Polymarket at 0% to X at 56%. No other tracker puts the two side by side.
31 analysts have weighed in: a Strong Buy consensus: 24 buy calls against 1 sell, with an average 12-month price target of $275.39.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 4 sources disagree sharply, so the read is a Sell.
Analysts sit 48 points above the crowd average of 29%, the professionals are more constructive than retail. The split is inside the crowd: X reads 56% bullish while Polymarket sits at 0%, a 56-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Abbvie (ABBV) buzz held moderate around 48.3 while the price drifted down 2.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 5.4M shares. Updated Aug 15, 2026. Over the last 7 trading days, ABBV gained 2.3%. Buzz activity in the recent week averaged 42.0 and was variable, swinging between 33.7 and 54.1. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 20 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
Query sentiment for ABBV and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ABBV sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 18, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (24 / 6 / 1) |
| Crowd bullish (7d) | 29% |
| Avg price target | $275.39 |
| Most bullish source | X, 56% |
| Most bearish source | Polymarket, 0% |
| Sentiment spread | 56 pts |
| Mentions (7d) | 75 |
| Market cap | $440.83B |
| P/E · Forward P/E | 70.9 · 17.6 |
| EPS · Beta | $3.52 · 0.3 |
| Revenue (TTM) | $64.39B · 10% margin |
| Industry | Drug Manufacturers - General |
Based on aggregated sentiment from Reddit, X, News and Polymarket sources, Abbvie (ABBV) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 29% bullish across 4 active sources. Those sources contribute 75 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Abbvie (ABBV) is fairly quiet with 10 mentions over the last 7 days; the 30-day context spans 17 tracked subreddits. The 7-day tone is 50% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bearish on Abbvie (ABBV), averaging 29% bullish across 4 tracked sources over the last 7 days. The two ends of the range are X at 56% bullish and Polymarket at 0%, a 56-point spread. On the professional side, 24 of 31 analysts rate ABBV a buy.
Of the 31 analysts covering Abbvie (ABBV), 24 rate it a buy, 6 a hold and 1 a sell, for a strong buy consensus. The average price target is $275.39. That puts the street ahead of the crowd, which averages 29% bullish.
Abbvie (ABBV)'s cross-source average is bearish at 29% bullish. Source readings are split: 1 source leans bullish, 2 sources lean bearish and 1 source sits at 50% bullish. Reddit reads 50% bullish, X reads 56% bullish, News reads 9% bullish and polymarket coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Abbvie (ABBV) at 29% bullish. Source readings are split: 1 source leans bullish, 2 sources lean bearish and 1 source sits at 50% bullish. The most bearish reading is polymarket at 0% bullish. 3-day activity momentum is falling across Reddit and X and News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 34 mentions (45% of total volume). News contributes 31 mentions and Reddit contributes 10 mentions. The cross-source average is bearish at 29% bullish. Source readings are split: 1 source leans bullish, 2 sources lean bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ABBV's sell signal at 93/100 conviction reflects a bearish cross-source average at 29% bullish. Source readings are split: 1 source leans bullish, 2 sources lean bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The ABBV sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key